MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Theravance Company Profile (NASDAQ:THRX)

Consensus Ratings for Theravance (NASDAQ:THRX) (?)
Ratings Breakdown: 2 Sell Rating(s), 4 Hold Rating(s)
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $17.40 (3.14% upside)

Current Analysts' Coverage Summary for Theravance (NASDAQ:THRX)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2015Cowen and CompanyDowngradeOutperform -> Market Perform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Bank of AmericaBoost Price Target$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Leerink SwannDowngradeOutperform -> Market Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014Robert W. BairdDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Morgan StanleyDowngradeBuy -> Neutral$34.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Stifel NicolausDowngradeUnderweight$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2014Citigroup Inc.DowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/19/2013Sanford C. BernsteinBoost Price TargetMarket Perform$30.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)